Novartis posts Q2 sales growth, backs 2026 outlook on newer drug strength

Markets Investing.com By Investing.com 21 Jul 2026 05:54 1 min read

Novartis posts Q2 sales growth, backs 2026 outlook on newer drug strength

Novartis posts Q2 sales growth, backs 2026 outlook on newer drug strength

Novartis posts Q2 sales growth, backs 2026 outlook on newer drug strength

Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.